MDGL — Madrigal Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Annual balance sheet for Madrigal Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	284	270	359	634	926
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	53.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	285	272	361	637	1,033
Net Property, Plant And Equipment	1.83	1.65	1.2	3.27	4.59
Net Intangible Assets
Total Assets	287	273	363	641	1,042
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	46.6	76.8	116	119	169
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	47	77.2	165	235	288
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	240	196	197	405	754
Total Liabilities & Shareholders' Equity	287	273	363	641	1,042
Total Common Shares Outstanding
Total Preferred Shares Outstanding